NCT01737203View on ClinicalTrials.gov

Bioequivalence Study For Orally-Disintegrating Tablet Of Sildenafil

PHASE1CompletedINTERVENTIONAL
Enrollment

53

Participants

Timeline

Start Date

August 31, 2012

Primary Completion Date

September 30, 2012

Study Completion Date

September 30, 2012

Conditions
Healthy
Interventions
DRUG

Viagra

50 mg tablet on Day 1 of each period

DRUG

sildenafil ODT

50 mg tablet on Day 1 of each period

DRUG

sildenafil ODT

50 mg tablet on Day 1 of each period

Trial Locations (1)

Unknown

Pfizer Investigational Site, Minato-ku

All Listed Sponsors
lead

Pfizer's Upjohn has merged with Mylan to form Viatris Inc.

INDUSTRY

NCT01737203 - Bioequivalence Study For Orally-Disintegrating Tablet Of Sildenafil | Biotech Hunter | Biotech Hunter